If you're lacking these vitamins, making DNA is hard, causing the immature red blood cells to die
And in many cases, their physical transformations are visually remarkable
The number going down was the easy part to track
Eliquis (Pfizer/Bristol Myers Squibb) holds firm at $22.4B, Dupixent (Sanofi/Regeneron) climbs to $17.8B, and Skyrizi (AbbVie) at $17.6B - a strong signal that immunology remains highly profitable, even as Humira biosimilars continue to dominate
Four on liraglutide 2.4 mg discontinued because of injection-site disorders (pain/extravasation
This August, Eli Lilly announced that it would begin selling more affordable versions of Zepbound, with a months supply running between $400 and $550 depending on the dosage